To Evaluate and study analgesic effect of fentanyl as an additive to intrathecal hyperbaric ropivacaine for lower limb surgery
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/05/052455
- Lead Sponsor
- Dr. Sarvjeet Kaur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients scheduled for elective lower limb surgeries under spinal anaesthesia.
2.Patients aged between 18-60 years of either gender, giving valid informed and written consent.
3.Patients belonging to American Society of Anaesthesiology (ASA) grade I and II.
1.Patient with Known allergy to drugs used in study
2.Any contraindications to spinal anaesthesia
3.Coagulopathy and bleeding diathesis
4.Patients diagnosed with psychiatric ailments
5.History of drug/substance abuse
6.Patients on anti arrhythmic treatment
BMI >35 kg/m2
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To study duration of analgesia with intrathecal ropivacaine in lower limb surgery. <br/ ><br>2.To study duration of analgesia with intrathecal ropivacaine and fentanyl in lower limb surgery. <br/ ><br>3.To compare duration of analgesia with intrathecal ropivacaine versus intrathecal ropivacaine with fentanyl in lower limb surgery. <br/ ><br>Timepoint: Outcome will be assessed at the end of study that is 12 months
- Secondary Outcome Measures
Name Time Method ATimepoint: NA